IOVANCE BIOTHERAPEUTICS, INC. Inventory, Raw Materials, Net of Reserves
IOVANCE BIOTHERAPEUTICS, INC. (IOVA) had Inventory, Raw Materials, Net of Reserves of $30.79 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Inventory, Net, Items Net of Reserve Alternative
us-gaap:InventoryRawMaterialsNetOfReserves · last filed 2026-08-06
- 2026-06-30: Inventory, Raw Materials, Net of Reserves $30.79M.
- 2026-03-31: Inventory, Raw Materials, Net of Reserves $34.24M.
- 2025-12-31: Inventory, Raw Materials, Net of Reserves $31.68M.
- 2025-09-30: Inventory, Raw Materials, Net of Reserves $35.70M.
| Period end | Inventory, Raw Materials, Net of Reserves |
|---|---|
| 2026-06-30 | $30.79M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $34.24M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $31.68M 10-Q · filed 2026-08-06 |
| 2025-09-30 | $35.70M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $34.49M 10-Q · filed 2025-08-07 |
| 2025-03-31 | $37.91M 10-Q · filed 2025-05-08 |
| 2024-12-31 | $27.74M 10-K · filed 2026-02-24 |
| 2024-09-30 | $23.89M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $12.98M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $5.57M 10-Q · filed 2024-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Adaptive Biotechnologies Corp (ADPT) | United States | $4.719B | -53.43 |
| CRISPR Therapeutics AG (CRSP) | $5.390B | -11.68 | |
| Relay Therapeutics, Inc. (RLAY) | United States | $3.884B | -14.30 |
| Scholar Rock Holding Corp (SRRK) | United States | $5.920B | -16.37 |
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| Tarsus Pharmaceuticals, Inc. (TARS) | United States | $3.329B | -58.60 |
| Denali Therapeutics Inc. (DNLI) | United States | $3.274B | -8.04 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Greenland Mines Ltd (GRML) | United States | $2.362B |